Copyright © Philip M. Parker, INSEAD. Terms of Use.
| Year | Description |
| 2001 | Invention patented by Anton Franz Fliri, Todd William Butler, and Randall James Gallaschun on August 31th, 2001. Abstract: The present invention is directed to a compound of the formula (I): ##STR1## and pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, Y, U, W, k, A, E, V, R.sup.4 and R.sup.5 are as defined herein, pharmaceutical compositions thereof, and methods of use thereof in the inhibition of serotonin reuptake, the inhibition of the binding of 5-HT.sub.2A serotonin receptors and the treatment of diseases, conditions or disorders of the central nervous system. Further, the present invention is also directed to methods for the preparation of compounds of formula (I) and intermediates useful therefor. |
| Source: selected by the editor from original sources. | |
Copyright © Philip M. Parker, INSEAD. Terms of Use.
